Tıp Öğrencileri Arasında COVID-19 Aşı Tereddütü ve İlişkili Faktörler, Bolu Örneği
Öz
Anahtar Kelimeler
Teşekkür
Kaynakça
- 1. Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, et al. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. BioMed Central; 2020. p. 1-5.
- 1. Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, et al. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. BioMed Central; 2020. p. 1-5.
- 2. Sharun K, Tiwari R, Dhama J, Dhama K. Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence. International Journal of Surgery (London, England). 2020;82:179.
- 2. Sharun K, Tiwari R, Dhama J, Dhama K. Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence. International Journal of Surgery (London, England). 2020;82:179.
- 3. Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020:576-7.
- 3. Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020:576-7.
- 4. Alsubaie SS, Gosadi IM, Alsaadi BM, Albacker NB, Bawazir MA, Bin-Daud N, et al. Vaccine hesitancy among Saudi parents and its determinants: Result from the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Medical Journal. 2019;40(12):1242.
- 4. Alsubaie SS, Gosadi IM, Alsaadi BM, Albacker NB, Bawazir MA, Bin-Daud N, et al. Vaccine hesitancy among Saudi parents and its determinants: Result from the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Medical Journal. 2019;40(12):1242.
Ayrıntılar
Birincil Dil
Türkçe
Konular
İç Hastalıkları
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
23 Aralık 2022
Gönderilme Tarihi
27 Nisan 2022
Kabul Tarihi
17 Ekim 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 16 Sayı: 4